[Low-field magnetic resonance imaging : Just less expensive or completely different?] [0.03%]
低成本磁共振成像技术：仅仅是便宜还是完全不同？
Jürgen Hennig
Jürgen Hennig
Over the years the development of field strength in magnetic resonance imaging (MRI) has continued to increase from the low-field systems in the early years (0.2-0.5 T) to 1.5 T to 3 T to 7 T and more. In the last 2 years, there has been a ...
M K Meier,T D Lerch,M S Hanke et al.
M K Meier et al.
Instability and impingement of the hip are the main pathomechanisms that can lead to chondrolabral damage, painful restriction of motion and early hip osteoarthritis due to increased mechanical stress, even in young patients. The goals of j...
Thomas Helmberger
Thomas Helmberger
[Integrated care concepts and multidisciplinary process chains in a radiological context] [0.03%]
[放射学背景下的综合护理概念和多学科过程链]
J Bauer,E Kösel,A G Henkel et al.
J Bauer et al.
Modern patient-centered and cost-efficient care concepts in hospitals require the mapping of multidisciplinary process chains into clinical pathways. Clinical decision support systems and operations research methods use algorithms to classi...
[New clinical applications for low-field magnetic resonance imaging : Technical and physical aspects] [0.03%]
低场磁共振成像的新临床应用：技术及物理特性方面的问题探讨
Hanns-Christian Breit,Jan Vosshenrich,Michael Bach et al.
Hanns-Christian Breit et al.
Background: Low-field magnetic resonance imaging (MRI) is experiencing a renaissance due to technical innovations. The new-generation devices offer new applications for imaging and a possible solution to increasing cost p...
[International comparison of radiological aspects of the new German S3 guideline on hepatocellular carcinoma and intrahepatic cholangiocarcinoma] [0.03%]
[德国肝细胞癌和肝内胆管癌新S3指南放射学内容的国际比较]
Philippe L Pereira,Thomas J Vogl,Thomas Helmberger
Philippe L Pereira
The updated German S3 guideline "Diagnostics and therapy of hepatocellular carcinoma and biliary carcinomas" covers two tumor entities. The original guideline published in 2013 focusing only on the diagnosis and therapy of hepatocellular ca...
[Transarterial radioembolization of hepatocellular carcinoma and intrahepatic cholangiocarcinoma] [0.03%]
肝细胞癌和肝内胆管癌的经动脉放射性微球栓塞治疗
Thomas Helmberger,Philippe L Pereira
Thomas Helmberger
Since the first version of the S3 guideline for the diagnosis and treatment of hepatocellular carcinoma (HCC) in 2013, a large number of studies have consolidated the data on transarterial radioembolization (TARE) and created a broad eviden...
Peter Huppert
Peter Huppert
Transarterial chemoembolization (TACE) is used as palliative and neoadjuvant treatment for patients with hepatocellular carcinoma (HCC). TACE should be offered as palliative treatment to patients with intermediate stage large or multinodula...
[Future perspectives: how does artificial intelligence influence the development of our profession?] [0.03%]
[未来展望：人工智能如何影响我们职业的发展？]
Ulrike Attenberger,Maximilian F Reiser
Ulrike Attenberger
[Clinical relevance of the new S3 guideline on hepatocellular carcinoma and biliary tract cancer for practitioners] [0.03%]
新版德国肝细胞癌和胆道系统癌症诊疗指南(S3)的临床意义-专家意见论文摘要编译
Sabrina Voesch,M Bitzer,N Malek
Sabrina Voesch
The update of the S3 German guideline for the management of the hepatocellular carcinoma and biliary tract cancer contains a comprehensive revision of the guideline for hepatocellular carcinoma and establishes a new guideline for biliary tr...